Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01839747 · ClinicalTrials.gov registry record · NA
Evaluation of PET/MRI in Children With Cancer
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 8
- Enrollment target
NCT01839747: Completed NA study, sponsored by Massachusetts General Hospital.
NCT01839747 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 8 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01839747, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
Study Summary
This research study is a Pilot study (a small preliminary study to assess the feasibility of a larger, more in depth study involving a new test or procedure) and is being done to evaluate the feasibility and accuracy of PET/MRI in the evaluation of cancer. PET/MRI is a FDA approved technology that is currently being studied to assess its accuracy and utility in the diagnosis and management of a variety of diseases and patient populations. The focus of this particular study will be to compare the performance of PET/MRI in its ability to detect and characterize cancerous tumors using positron emission topography and computed tomography (PET/CT) as a reference standard.
Interventions
- PROCEDURE PET-CT
- PROCEDURE PET-MRI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2012-10-31 |
| Est. Completion | 2025-01-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01839747
The ClinicalTrials.gov registry entry for NCT01839747 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which PET-CT is the first listed.
NCT01839747 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01839747 about?
NCT01839747 is a clinical study titled "Evaluation of PET/MRI in Children With Cancer". This research study is a Pilot study (a small preliminary study to assess the feasibility of a larger, more in depth study involving a new test or procedure) and is being done to evaluate the feasibility and accuracy of PET/MRI in the evaluation of cancer. PET/MRI is a FDA approved technology that i...
What is the current status of trial NCT01839747?
This trial is currently completed. It is a NA study. The enrollment target is 8 participants. The study started on 2012-10-31. Estimated completion is 2025-01-15.
What interventions are being tested in trial NCT01839747?
The interventions under investigation include: PET-CT (PROCEDURE), PET-MRI (PROCEDURE).
Who is sponsoring clinical trial NCT01839747?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.